ETF Exchange > PPH ETF
PPH - ETF Fact Sheet
VanEck Pharmaceutical ETF - USD
Fund Identification
Ticker
PPH
ISIN
US92189F6925
Main Metrics
Price
$115.49Expense Ratio
0.36%AuM
$1,055.39MTracking Difference
0.17%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
PPH's historical prices, performance, and flows
1m returns
4.66%
1m flows
$85M
* Net total returns
All data as of 2 September 2026
The ETF Exchange is brought to you by
With data and analysis by
See all PPH data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
PPH's characteristics
Manager
Manager statistics
197 funds, $239.68Bn in AUM
Benchmark
MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
PPH's exposure
Countries
USA
60.93%
United Kingdom
11.44%
Switzerland
10.54%
Other
17.10%
Sectors
Healthcare
100.00%
Top 5 holdings
Eli Lilly & Co.
19.11%
Novartis AG
10.54%
Merck & Co., Inc.
9.76%
Novo Nordisk A/S
5.67%
Bristol Myers Squibb Co.
4.94%
Total holdings
25
Total weight of top 5
50.02%